Malcolm Mason
Impact in
-
- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Treatment and Research
- Gastric Cancer Management and Outcomes
-
- Bladder and Urothelial Cancer Treatments
- Urinary and Genital Oncology Studies
Papers in
-
- Prostate Cancer Diagnosis and Treatment 4
- Prostate Cancer Treatment and Research 2
- Gastric Cancer Management and Outcomes 2
- Renal cell carcinoma treatment 1
- Surgery 6
- Bladder and Urothelial Cancer Treatments 3
- Cholangiocarcinoma and Gallbladder Cancer Studies 2
- Co-authors
- Jim Barber (1 shared paper)Matthew R. Sydes (1 shared paper)Andrea Hiltz (1 shared paper)Michael Brundage (1 shared paper)Padraig Warde (1 shared paper)Jinka Sathya (1 shared paper)John Anderson (1 shared paper)Mahesh Parmar (1 shared paper)
- Journals
- Clinical Oncology (2 papers)Cancer Research (2 papers)European Urology (1 paper)The Journal of Urology (1 paper)Journal of drug targeting (1 paper)
- Partner nations
- United KingdomUnited StatesItaly
In The Last Decade
Malcolm Mason
13 papers receiving 673 citations
Malcolm Mason's Hit Papers
Peers
Comparison fields: 5 of 56
- Pulmonary and Respiratory Medicine 374
- Surgery 209
- Radiation 38
- Cancer Research 54
- Oncology 95
Countries citing papers authored by Malcolm Mason
This map shows the geographic impact of Malcolm Mason's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Malcolm Mason with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Malcolm Mason more than expected).
Fields of papers citing papers by Malcolm Mason
This network shows the impact of papers produced by Malcolm Mason. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Malcolm Mason. The network helps show where Malcolm Mason may publish in the future.
Co-authors
The 25 scholars most cited alongside Malcolm Mason, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial Hit paper breakdown → | 2011 | 385 |
| 2 | 2012 | 169 | |
| 3 | 2000 | 25 | |
| 4 | 1984 | 24 | |
| 5 | 2012 | 18 | |
| 6 | Re: Intravesical Bacillus Calmette-Guerin versus Mitomycin C for Ta and T1 Bladder Cancer Shelley MD, Court JB, Kynaston H, Wilt TJ, Coles B, | 2006 | 16 |
| 7 | 2010 | 15 | |
| 8 | 2014 | 15 | |
| 9 | 2013 | 6 | |
| 10 | 2014 | 5 | |
| 11 | 2015 | 5 | |
| 12 | NUC-1031: A novel ProTide that overcomes the key cancer resistance mechanisms associated with poor survival | 2014 | 2 |
| 13 | 2012 | 2 | |
| 14 | Inhibitory effect of Yangzheng Xiaoji on the ARK/Aurora pathways and in vivo tumour growth of human osteosarcoma | 2013 | 0 |
About Malcolm Mason
Malcolm Mason is a scholar working on Pulmonary and Respiratory Medicine, Surgery, Molecular Biology, Oncology and Infectious Diseases, having authored 14 papers that have together received 687 indexed citations. Recurring topics across this work include Prostate Cancer Diagnosis and Treatment (4 papers), Bladder and Urothelial Cancer Treatments (3 papers), Prostate Cancer Treatment and Research (2 papers), Gastric Cancer Management and Outcomes (2 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers), Multiple and Secondary Primary Cancers (1 paper), Urologic and reproductive health conditions (1 paper) and Renal cell carcinoma treatment (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (374 citations), Surgery (209 citations), Radiation (38 citations), Cancer Research (54 citations) and Oncology (95 citations). Malcolm Mason has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Jim Barber, Matthew R. Sydes, Andrea Hiltz, Michael Brundage, Padraig Warde, Jinka Sathya, John Anderson, Mahesh Parmar, Mary Gospodarowicz and Wendy R. Parulekar. Their work appears in journals such as Clinical Oncology, Cancer Research, European Urology, The Journal of Urology and Journal of drug targeting.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.